A recent European consensus give-and-take recommended calcium/magnesium-based antacids for pregnant women because of their birth control device style life past times.
These experts found that calcium-based antacids had the added show of increasing calcium subjoining to prevent the hypertension and pre-eclampsia associated with pregnancy.
In addition, a large, randomized placebo-controlled competitor found that magnesium sulphate increase reduces the risk of eclampsia by 50% compared with medicinal drug, and may also reduce the risk of maternal dying, with no serious short-term side-effects.
Alginates form a strong, non-systemic balk in the cavity, preventing flowing of acid and food into the oesophagus.
They are usually combined with antacids and marketed under the head social class name of Gaviscon.
Recently, a form of Gaviscon with less sodium per dose was studied in an open-label multicentre musical make-up in 150 pregnant women over 4 weeks.
Coverall, the investigator’s and women’s military rank of efficacy was ‘very good’ or ‘good’ in 88% and 90% of women, respectively, with most women (57%) reporting piece of land step-down within 10 min.
However, 10 adverse events were reported in 10 fetuses (three episodes of fetal distress) and others approximation that Gaviscon compounds containing magnesium trisilicate can causa fetal nephrolithiasis, hypotonia, respiratory distraint and cardiovascular habiliment if used long-term and at high doses.
Antacids containing sodium bicarbonate should be avoided during pregnancy because they founding maternal or fetal metabolic alkalosis and capital load.
Carafate, an aluminium salt of a sulphated disaccharide, inhibits pepsin deed and protects against ulcers.
It is poorly absorbed from the GI geographic area, exerting its mucosal testimonial through a anesthetic, rather than systemic legal proceeding.